Funding

NorthLinks Bio

United States · Biotech · Healthtech · Enterprise software

Develops broad-spectrum antiviral prophylactic therapies for respiratory infections

Visit northlinksbio.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Undisclosed$34MRA Capital Management — Role not disclosed

Investors

RA Capital ManagementUndisclosed

Coverage

Jun 23, 2026NorthLinks Bio · Undisclosed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Sourcesnorthlinksbio.com ↗